MilleGen Ab PHARMA: Therapeutic Antibodies
MilleGen Pharma division is expert in the development of human monoclonal antibody-based-therapies for the treatment of cancers. MilleGen proprietary protein engineering technologies allow to develop better biotherapeutics.
Fully human monoclonal antibodies are selected from an optimized quality library (MG-Umab library) to develop targeted immunotherapies.
Our genetic antibody maturation technology allows antibody binding maturation to its target as well as Fc engineering to enhance therapeutic efficacy. MilleGen is developing the third generation of therapeutic antibodies with improved clinical outcomes.
MilleGen SERVICES: DNA Sequencing, Molecular Biology and Peptide Synthesis
MilleGen provides 11 years of experience and expertise in biotechnology services including High-Throughput DNA Sequencing, Molecular Biology projects, Bioinformatics, Peptides Synthesis and Antibodies Sequencing.
|
